Sarcoma Program

Moffitt Cancer Center's Sarcoma Program specializes in the evaluation and treatment of more than 50 unique sarcomas, including rare epithelial sarcomas, dermatofibrosarcoma protuberans (DFSP) and desmoplastic small round cell tumors. As a high-volume cancer center with one of the most specialized sarcoma programs in the country, Moffitt is one of the most trusted names for referring physicians nationwide. Our advanced program accepts referrals for both adult and pediatric sarcoma patients, as well as patients who require further diagnostic testing to confirm or rule out a sarcoma diagnosis.

With a single referral, physicians can arrange for their patients to consult with several medical professionals in a single clinic. Patients in Moffitt's Sarcoma Program have the ability to consult with:

  • Diagnostic, screening and staging specialists
  • Medical oncologists
  • Radiation oncologists
  • Orthopaedic oncologists
  • Surgical oncologists
  • Reconstructive surgeons
  • Pathologists
  • Specialized radiologists
  • Nutritionists and other supportive care providers

This multispecialty team of experts collaboratively assesses each patient's case to determine the most promising therapies and integrative treatments. Our offerings include some of the latest advancements in sarcoma treatment, including molecular targeted therapeutics, complex reconstruction surgeries, experimental vaccines and immunotherapies, noninvasive expandable limb implants and limb salvage surgeries. Our robust clinical trials program also gives patients the opportunity to access innovative therapies – such as the anti-PD1 antibody Pembrolizumab and the oral chemotherapy drug Regorafenib – before they are approved for use in other settings. And, once treatment is underway, our tumor board reviews the patient’s progress to determine if any adjustments are necessary.

To refer a patient to Moffitt's Sarcoma Program, fill out our online form or contact a physician liaison. To keep referral times as short as possible, we respond to virtually all online referrals on the same day in which they are received.